The aim of this study is to determine whether patients in the Intensive Care Unit who receive
fluid resuscitation with either hydroxyethyl starch (a synthetic colloid solution) or saline
(a salt solution), have an increased rate of survival at 90 days.
Phase:
Phase 3
Details
Lead Sponsor:
The George Institute
Collaborators:
Australian and New Zealand Intensive Care Society Clinical Trials Group Fresenius Kabi University of Sydney